Derfor var CHMP ikke enig i, at sikkerheds - og effektprofilen for Rapinyl kunne forudses ud fra den leverede dokumentation.
Therefore, the CHMP was unable to agree that the safety and efficacy profile of Rapinyl could be anticipated from the provided documentation.